{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:13:00Z","timestamp":1794337980112,"version":"4.9.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA136493"],"award-info":[{"award-number":["R01CA136493"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA136493"],"award-info":[{"award-number":["R01CA136493"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UAMS Clinical and Translational Sciences Certificate in Oncology Intramural Mentoring Program"},{"DOI":"10.13039\/100006108","name":"U.S. Department of Health &amp; Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1U54TR001629-01A1"],"award-info":[{"award-number":["1U54TR001629-01A1"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Sturgis Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cytosolic Malic Enzyme (ME1) provides reduced NADP for anabolism and maintenance of redox status. To examine the role of ME1 in tumor genesis of the gastrointestinal tract, we crossed mice having augmented intestinal epithelial expression of ME1 (ME1-Tg mice) with Apc<jats:sup>Min\/+<\/jats:sup> mice to obtain male Apc<jats:sup>Min\/+<\/jats:sup>\/ME1-Tg mice. ME1 protein levels were significantly greater within gut epithelium and adenomas of male Apc<jats:sup>Min\/+<\/jats:sup>\/ME1-Tg than Apc<jats:sup>Min\/+<\/jats:sup> mice. Male Apc<jats:sup>Min\/+<\/jats:sup>\/ME1-Tg mice had larger and greater numbers of adenomas in the small intestine (jejunum and ileum) than male Apc<jats:sup>Min\/+<\/jats:sup> mice. Male Apc<jats:sup>Min\/+<\/jats:sup>\/ME1-Tg mice exhibited greater small intestine crypt depth and villus length in non-adenoma regions, correspondent with increased KLF9 protein abundance in crypts and <jats:italic>lamina propria<\/jats:italic>. Small intestines of male Apc<jats:sup>Min\/+<\/jats:sup>\/ME1-Tg mice also had enhanced levels of <jats:italic>Sp5<\/jats:italic> mRNA, suggesting Wnt\/\u03b2-catenin pathway activation. A small molecule inhibitor of ME1 suppressed growth of human CRC cells <jats:italic>in vitro<\/jats:italic>, but had little effect on normal rat intestinal epithelial cells. Targeting of ME1 may add to the armentarium of therapies for cancers of the gastrointestinal tract.<\/jats:p>","DOI":"10.1038\/s41598-018-32532-w","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T11:22:31Z","timestamp":1537269751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Malic Enzyme 1 (ME1) is pro-oncogenic in ApcMin\/+ mice"],"prefix":"10.1038","volume":"8","author":[{"given":"Lorenzo M.","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Dwairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia C. M.","family":"Simmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Marji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah W.","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6842-7754","authenticated-orcid":false,"given":"Frank A.","family":"Simmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"key":"32532_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molcel.2015.11.005","volume":"60","author":"E Balsa-Martinez","year":"2015","unstructured":"Balsa-Martinez, E. & Puigserver, P. Cancer cells hijack gluconeogenic enzymes to fuel cell growth. Molecular Cell 60, 509\u2013511 (2015).","journal-title":"Molecular Cell"},{"key":"32532_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metabolism 23, 27\u201347 (2016).","journal-title":"Cell Metabolism"},{"key":"32532_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bj.2015.10.002","volume":"39","author":"A Hjelmeland","year":"2016","unstructured":"Hjelmeland, A. & Zhang, J. Metabolic, autophagic, and mitophagic activities in cancer initiation and progression. Biomedical Journal 39, 98\u2013106 (2016).","journal-title":"Biomedical Journal"},{"key":"32532_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden, M. G. & DeBerardinis, R. J. Understanding the intersections between metabolism and cancer biology. Cell 168, 657\u2013669 (2017).","journal-title":"Cell"},{"key":"32532_CR5","doi-asserted-by":"publisher","first-page":"E7697","DOI":"10.1073\/pnas.1710366114","volume":"114","author":"K Satoh","year":"2017","unstructured":"Satoh, K. et al. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC. Proc. Natl. Acad. Sci. USA 114, E7697\u2013E7706 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"32532_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0014-5793(94)00386-6","volume":"344","author":"G Loeber","year":"1994","unstructured":"Loeber, G., Dworkin, M. B., Infante, A. & Ahorn, H. Characterization of cytosolic malic enzyme in human tumor cells. FEBS Lett. 344, 181\u2013186 (1994).","journal-title":"FEBS Lett."},{"key":"32532_CR7","doi-asserted-by":"publisher","first-page":"12721","DOI":"10.1021\/bi035251+","volume":"42","author":"GG Chang","year":"2003","unstructured":"Chang, G. G. & Tong, L. Structure and function of malic enzymes, a new class of oxidative decarboxylases. Biochemistry 42, 12721\u201312733 (2003).","journal-title":"Biochemistry"},{"key":"32532_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature21052","volume":"542","author":"P Dey","year":"2017","unstructured":"Dey, P. et al. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. Nature 542, 119\u2013123 (2017).","journal-title":"Nature"},{"key":"32532_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.34","volume":"6","author":"S Murai","year":"2017","unstructured":"Murai, S. et al. Inhibition of malic enzyme 1 disrupts cellular metabolism and leads to vulnerability in cancer cells in glucose-restricted conditions. Oncogenesis 6, e329 (2017).","journal-title":"Oncogenesis"},{"key":"32532_CR10","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1002\/elps.200800806","volume":"30","author":"YK Shin","year":"2009","unstructured":"Shin, Y. K. et al. Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance. Electrophoresis 30, 2182\u20132192 (2009).","journal-title":"Electrophoresis"},{"key":"32532_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep05414","volume":"4","author":"J-G Ren","year":"2014","unstructured":"Ren, J.-G. et al. Knockdown of malic enzyme 2 suppresses lung tumor growth, induces differentiation and impacts PI3K\/AKT signaling. Sci. Rep. 4, 5414 (2014).","journal-title":"Sci. Rep."},{"key":"32532_CR12","doi-asserted-by":"publisher","first-page":"G868","DOI":"10.1152\/ajpgi.00515.2007","volume":"294","author":"R Xiao","year":"2008","unstructured":"Xiao, R., Su, Y., Simmen, R. C. M. & Simmen, F. A. Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G868\u201376 (2008).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"32532_CR13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez, J. A. & Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7, 763\u2013777 (2007).","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"32532_CR14","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1158\/0008-5472.CAN-11-4057","volume":"72","author":"YY Zaytseva","year":"2012","unstructured":"Zaytseva, Y. Y. et al. Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer. Cancer Res. 72(6), 1504\u201317 (2012).","journal-title":"Cancer Res."},{"key":"32532_CR15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nature11776","volume":"493","author":"P Jiang","year":"2013","unstructured":"Jiang, P., Du, W., Mancuso, A., Wellen, K. E. & Yang, X. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 493, 689\u2013693 (2013).","journal-title":"Nature"},{"key":"32532_CR16","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/cdd.2017.63","volume":"24","author":"H Shen","year":"2017","unstructured":"Shen, H. et al. MicroRNA-30a attenuates mutant KRAS-driven colorectal tumorigenesis via direct suppression of ME1. Cell Death Differ. 24, 1253\u20131262 (2017).","journal-title":"Cell Death Differ."},{"key":"32532_CR17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/000313480507100413","volume":"71","author":"J-S Hsieh","year":"2005","unstructured":"Hsieh, J.-S. et al. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Am. Surg. 71, 336\u201343 (2005).","journal-title":"Am. Surg."},{"key":"32532_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-015-0457-x","volume":"10","author":"G Chakrabarti","year":"2015","unstructured":"Chakrabarti, G. Mutant KRAS associated malic enzyme 1 expression is a predictive marker for radiation therapy response in non-small cell lung cancer. Radiat. Oncol. 10, 145 (2015).","journal-title":"Radiat. Oncol."},{"issue":"11","key":"32532_CR19","doi-asserted-by":"publisher","first-page":"e113058","DOI":"10.1371\/journal.pone.0113058","volume":"9","author":"A Al-Dwairi","year":"2014","unstructured":"Al-Dwairi, A. et al. Enhanced gastrointestinal expression of cytosolic malic enzyme (ME1) induces intestinal and liver lipogenic gene expression and intestinal cell proliferation in mice. PLoS One 9(11), e113058 (2014).","journal-title":"PLoS One"},{"issue":"10","key":"32532_CR20","doi-asserted-by":"publisher","first-page":"e46716","DOI":"10.1371\/journal.pone.0046716","volume":"7","author":"A Al-Dwairi","year":"2012","unstructured":"Al-Dwairi, A., Pabona, J. M. P., Simmen, R. C. M. & Simmen, F. A. Cytosolic malic enzyme 1 (ME1) mediates high fat diet-induced adiposity, endocrine profile, and gastrointestinal tract proliferation-associated biomarkers in male mice. PLoS One 7(10), e46716 (2012).","journal-title":"PLoS One"},{"key":"32532_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/path.4645","volume":"238","author":"R Jackstadt","year":"2016","unstructured":"Jackstadt, R. & Sansom, O. J. Mouse models of intestinal cancer. Journal of Pathology 238, 141\u2013151 (2016).","journal-title":"Journal of Pathology"},{"key":"32532_CR22","first-page":"1483","volume":"27","author":"M Takahashi","year":"2005","unstructured":"Takahashi, M., Nakamura, Y., Obama, K. & Furukawa, Y. Identification of SP5 as a downstream gene of the beta-catenin\/Tcf pathway and its enhanced expression in human colon cancer. Int J Oncol. 27, 1483\u20137 (2005).","journal-title":"Int J Oncol."},{"key":"32532_CR23","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.bbrc.2005.12.068","volume":"340","author":"Y Chen","year":"2006","unstructured":"Chen, Y. et al. Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers. Biochem. Biophys. Res. Commun. 340, 758\u2013766 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"32532_CR24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1074\/jbc.M605851200","volume":"282","author":"N Fujimura","year":"2007","unstructured":"Fujimura, N. et al. Wnt-mediated down-regulation of Sp1 target genes by a transcriptional repressor Sp5. J. Biol. Chem. 282, 1225\u20131237 (2007).","journal-title":"J. Biol. Chem."},{"key":"32532_CR25","first-page":"G1757","volume":"292","author":"FA Simmen","year":"2007","unstructured":"Simmen, F. A. et al. Dysregulation of intestinal crypt cell proliferation and villus cell migration in mice lacking Kruppel-like factor 9. AJP Gastrointest. Liver Physiol. 292, G1757\u2013G1769 (2007).","journal-title":"Liver Physiol."},{"key":"32532_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bmcl.2005.10.065","volume":"16","author":"YJ Zhang","year":"2006","unstructured":"Zhang, Y. J., Wang, Z., Sprous, D. & Nabioullin, R. In silico design and synthesis of piperazine-1-pyrrolidine-2,5-dione scaffold-based novel malic enzyme inhibitors. Bioorganic Med. Chem. Lett. 16, 525\u2013528 (2006).","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"32532_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1158\/0008-5472.CAN-10-1282","volume":"71","author":"J Waaler","year":"2011","unstructured":"Waaler, J. et al. Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth. Cancer Res. 71, 197\u2013205 (2011).","journal-title":"Cancer Res."},{"key":"32532_CR28","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/ijc.24667","volume":"125","author":"M Mutoh","year":"2009","unstructured":"Mutoh, M. et al. Overexpression of low-density lipoprotein receptor and lipid accumulation in intestinal polyps in Min mice. Int. J. Cancer 125, 2505\u20132510 (2009).","journal-title":"Int. J. Cancer"},{"key":"32532_CR29","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/nrc2761","volume":"9","author":"DW Kufe","year":"2009","unstructured":"Kufe, D. W. Mucins in cancer: Function, prognosis and therapy. Nature Reviews Cancer 9, 874\u2013885 (2009).","journal-title":"Nature Reviews Cancer"},{"key":"32532_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0303-7207(01)00536-6","volume":"181","author":"XL Zhang","year":"2001","unstructured":"Zhang, X. L., Simmen, F. A., Michel, F. J. & Simmen, R. C. M. Increased expression of the Zn-finger transcription factor BTEB1 in human endometrial cells is correlated with distinct cell phenotype, gene expression patterns, and proliferative responsiveness to serum and TGF-\u03b21. Mol. Cell. Endocrinol. 181, 81\u201396 (2001).","journal-title":"Mol. Cell. Endocrinol."},{"key":"32532_CR31","doi-asserted-by":"publisher","first-page":"32742","DOI":"10.1074\/jbc.M114.588988","volume":"289","author":"M Ying","year":"2014","unstructured":"Ying, M. et al. Kruppel-like factor-9 (KLF9) inhibits glioblastoma stemness through global transcription repression and integrin \u03b16 inhibition. J. Biol. Chem. 289, 32742\u201332756 (2014).","journal-title":"J. Biol. Chem."},{"key":"32532_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00404-014-3405-3","volume":"291","author":"QH Zhang","year":"2015","unstructured":"Zhang, Q. H., Dou, H. T., Tang, Y. J., Su, S. & Liu, P. S. Lentivirus-mediated knockdown of Kr\u00fcppel-like factor 9 inhibits the growth of ovarian cancer. Arch Gynecol Obstet. 291, 377\u201382 (2015).","journal-title":"Arch Gynecol Obstet."},{"key":"32532_CR33","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/carcin\/bgv104","volume":"36","author":"AR Brown","year":"2015","unstructured":"Brown, A. R. et al. Kr\u00fcppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling. Carcinogenesis 36, 946\u2013955 (2015).","journal-title":"Carcinogenesis"},{"key":"32532_CR34","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.08.053","volume":"154","author":"AC Lloyd","year":"2013","unstructured":"Lloyd, A. C. The regulation of cell size. Cell 154, 1194\u2013205 (2013).","journal-title":"Cell"},{"key":"32532_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, 34\u20131 (2002).","journal-title":"Genome Biol."},{"issue":"2","key":"32532_CR36","doi-asserted-by":"publisher","first-page":"e54072","DOI":"10.1371\/journal.pone.0054072","volume":"8","author":"Quentin Geissmann","year":"2013","unstructured":"Geissmann, Q. OpenCFU, a new free and open-source software to count cell colonies and other circular objects. PLoS One 8 (2013).","journal-title":"PLoS ONE"},{"key":"32532_CR37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nature Methods 9, 676\u2013682 (2012).","journal-title":"Nature Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32532-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32532-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32532-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T09:42:04Z","timestamp":1671615724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32532-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["32532"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-32532-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"12 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14268"}}